FIELD: medicine, immunology. SUBSTANCE: method involves analysis of patient blood using the labeled antibodies and antibodies - immunoglobulins of class G to thymus hormone in patient serum blood are determined. T-Dependent immunodeficiency is diagnosed if antibody level - immunoglobulins of class G to thymus hormone in serum-negative serum is increased. Method can be used for diagnosis of damages in an organism immune system. EFFECT: simplified technological process, decreased cost and analysis time, total analysis. 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIGEN FOR FORMING INFANT PATHOLOGY RISK GROUPS AMONG PREGNANT | 1996 |
|
RU2121685C1 |
| METHOD OF PROGNOSIS OF FETAL THERAPY EFFECTIVENESS IN PATIENTS WITH ONCOLOGICAL SICKNESSES | 1996 |
|
RU2118819C1 |
| METHOD FOR SECONDARY IMMUNODEFICIENCY DIAGNOSTICS | 2020 |
|
RU2749781C1 |
| METHOD OF ASSAY OF ACTIVITY OF PATHOLOGICAL PROCESS IN PATIENTS WITH CEREBROSPINAL SCLEROSIS | 1997 |
|
RU2116651C1 |
| PREPARATION STIMULATING THE DIFFERENTIATION OF T-LYMPHOCYTES | 2001 |
|
RU2188032C1 |
| METHOD FOR EVALUATING MECHANISMS CONTROLLING ANTIBODYGENESIS | 1997 |
|
RU2143116C1 |
| METHODS OF FAST DETECTION OF RISK OF T-HELPER DEFICIENCY IN PEOPLE IN ARCTIC CONDITIONS | 2016 |
|
RU2614702C1 |
| METHOD OF INTEGRATED THERAPY FOR PATIENTS WITH ACUTE NONSPECIFIC INFLAMMATORY DISEASES OF UTERINE ADNEXA | 1996 |
|
RU2153898C2 |
| AGENT SHOWING IMMUNOMODULATING ACTIVITY | 1994 |
|
RU2080120C1 |
| IMMUNOMODULATING REMEDY | 1993 |
|
RU2034542C1 |
